Global Prostate Cancer Drugs Market Research Report 2021

Global Prostate Cancer Drugs Market Research Report 2021

Table of Contents
1 Prostate Cancer Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Segment by Type
1.2.1 Global Prostate Cancer Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Prostate Cancer Drugs Segment by Application
1.3.1 Prostate Cancer Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Prostate Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Drugs Revenue 2016-2027
1.4.2 Global Prostate Cancer Drugs Sales 2016-2027
1.4.3 Prostate Cancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Prostate Cancer Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Prostate Cancer Drugs Manufacturing Sites, Area Served, Product Type
2.5 Prostate Cancer Drugs Market Competitive Situation and Trends
2.5.1 Prostate Cancer Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prostate Cancer Drugs Players Market Share by Revenue
2.5.3 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostate Cancer Drugs Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Prostate Cancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Prostate Cancer Drugs Market Facts & Figures by Country
3.3.1 North America Prostate Cancer Drugs Sales by Country
3.3.2 North America Prostate Cancer Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostate Cancer Drugs Market Facts & Figures by Country
3.4.1 Europe Prostate Cancer Drugs Sales by Country
3.4.2 Europe Prostate Cancer Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostate Cancer Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Prostate Cancer Drugs Sales by Region
3.5.2 Asia Pacific Prostate Cancer Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prostate Cancer Drugs Market Facts & Figures by Country
3.6.1 Latin America Prostate Cancer Drugs Sales by Country
3.6.2 Latin America Prostate Cancer Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostate Cancer Drugs Sales by Country
3.7.2 Middle East and Africa Prostate Cancer Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Prostate Cancer Drugs Historic Market Analysis by Type
4.1 Global Prostate Cancer Drugs Sales Market Share by Type (2016-2021)
4.2 Global Prostate Cancer Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Prostate Cancer Drugs Price by Type (2016-2021)
5 Global Prostate Cancer Drugs Historic Market Analysis by Application
5.1 Global Prostate Cancer Drugs Sales Market Share by Application (2016-2021)
5.2 Global Prostate Cancer Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Prostate Cancer Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AbbVie Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Astellas Pharma
6.2.1 Astellas Pharma Corporation Information
6.2.2 Astellas Pharma Description and Business Overview
6.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Astellas Pharma Product Portfolio
6.2.5 Astellas Pharma Recent Developments/Updates
6.3 Astra Zeneca
6.3.1 Astra Zeneca Corporation Information
6.3.2 Astra Zeneca Description and Business Overview
6.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Astra Zeneca Product Portfolio
6.3.5 Astra Zeneca Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Johnson & Johnson Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sanofi Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 GlaxoSmithKline Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Merck Group
6.6.1 Merck Group Corporation Information
6.6.2 Merck Group Description and Business Overview
6.6.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Group Product Portfolio
6.7.5 Merck Group Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Novartis Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Amgen
6.9.1 Amgen Corporation Information
6.9.2 Amgen Description and Business Overview
6.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Amgen Product Portfolio
6.9.5 Amgen Recent Developments/Updates
6.10 Bayer HealthCare
6.10.1 Bayer HealthCare Corporation Information
6.10.2 Bayer HealthCare Description and Business Overview
6.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bayer HealthCare Product Portfolio
6.10.5 Bayer HealthCare Recent Developments/Updates
6.11 Ferring Pharmaceutical
6.11.1 Ferring Pharmaceutical Corporation Information
6.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Description and Business Overview
6.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Ferring Pharmaceutical Product Portfolio
6.11.5 Ferring Pharmaceutical Recent Developments/Updates
6.12 Janssen Pharmaceuticals
6.12.1 Janssen Pharmaceuticals Corporation Information
6.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Janssen Pharmaceuticals Product Portfolio
6.12.5 Janssen Pharmaceuticals Recent Developments/Updates
6.13 Endo Pharmaceuticals
6.13.1 Endo Pharmaceuticals Corporation Information
6.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Endo Pharmaceuticals Product Portfolio
6.13.5 Endo Pharmaceuticals Recent Developments/Updates
6.14 BMS
6.14.1 BMS Corporation Information
6.14.2 BMS Prostate Cancer Drugs Description and Business Overview
6.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 BMS Product Portfolio
6.14.5 BMS Recent Developments/Updates
6.15 Takeda Pharmaceuticals
6.15.1 Takeda Pharmaceuticals Corporation Information
6.15.2 Takeda Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Takeda Pharmaceuticals Product Portfolio
6.15.5 Takeda Pharmaceuticals Recent Developments/Updates
6.16 Northwest Biotherapeutics
6.16.1 Northwest Biotherapeutics Corporation Information
6.16.2 Northwest Biotherapeutics Prostate Cancer Drugs Description and Business Overview
6.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Northwest Biotherapeutics Product Portfolio
6.16.5 Northwest Biotherapeutics Recent Developments/Updates
6.17 Teva Pharmaceutical
6.17.1 Teva Pharmaceutical Corporation Information
6.17.2 Teva Pharmaceutical Prostate Cancer Drugs Description and Business Overview
6.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Teva Pharmaceutical Product Portfolio
6.17.5 Teva Pharmaceutical Recent Developments/Updates
6.18 Boehringer Ingelheim
6.18.1 Boehringer Ingelheim Corporation Information
6.18.2 Boehringer Ingelheim Prostate Cancer Drugs Description and Business Overview
6.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Boehringer Ingelheim Product Portfolio
6.18.5 Boehringer Ingelheim Recent Developments/Updates
6.19 Foresee Pharmaceuticals
6.19.1 Foresee Pharmaceuticals Corporation Information
6.19.2 Foresee Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Foresee Pharmaceuticals Product Portfolio
6.19.5 Foresee Pharmaceuticals Recent Developments/Updates
6.20 Tokai Pharmaceuticals
6.20.1 Tokai Pharmaceuticals Corporation Information
6.20.2 Tokai Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Tokai Pharmaceuticals Product Portfolio
6.20.5 Tokai Pharmaceuticals Recent Developments/Updates
6.21 Spectrum Pharmaceuticals
6.21.1 Spectrum Pharmaceuticals Corporation Information
6.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Spectrum Pharmaceuticals Product Portfolio
6.21.5 Spectrum Pharmaceuticals Recent Developments/Updates
7 Prostate Cancer Drugs Manufacturing Cost Analysis
7.1 Prostate Cancer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostate Cancer Drugs
7.4 Prostate Cancer Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostate Cancer Drugs Distributors List
8.3 Prostate Cancer Drugs Customers
9 Prostate Cancer Drugs Market Dynamics
9.1 Prostate Cancer Drugs Industry Trends
9.2 Prostate Cancer Drugs Growth Drivers
9.3 Prostate Cancer Drugs Market Challenges
9.4 Prostate Cancer Drugs Market Restraints
10 Global Market Forecast
10.1 Prostate Cancer Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostate Cancer Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Prostate Cancer Drugs by Type (2022-2027)
10.2 Prostate Cancer Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prostate Cancer Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Prostate Cancer Drugs by Application (2022-2027)
10.3 Prostate Cancer Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostate Cancer Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Prostate Cancer Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Drugs Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Prostate Cancer Drugs Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Prostate Cancer Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Prostate Cancer Drugs Covered in This Study
Table 5. Global Prostate Cancer Drugs Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Prostate Cancer Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Prostate Cancer Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Prostate Cancer Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Prostate Cancer Drugs Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Prostate Cancer Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Prostate Cancer Drugs Product Type
Table 12. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prostate Cancer Drugs Sales by Region (2016-2021) & (K MT)
Table 16. Global Prostate Cancer Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Prostate Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 19. North America Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 23. Europe Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Prostate Cancer Drugs Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Prostate Cancer Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Prostate Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Prostate Cancer Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Prostate Cancer Drugs Sales (K MT) by Type (2016-2021)
Table 39. Global Prostate Cancer Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Prostate Cancer Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Prostate Cancer Drugs Revenue Share by Type (2016-2021)
Table 42. Global Prostate Cancer Drugs Price (USD/MT) by Type (2016-2021)
Table 43. Global Prostate Cancer Drugs Sales (K MT) by Application (2016-2021)
Table 44. Global Prostate Cancer Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Prostate Cancer Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Prostate Cancer Drugs Revenue Share by Application (2016-2021)
Table 47. Global Prostate Cancer Drugs Price (USD/MT) by Application (2016-2021)
Table 48. AbbVie Corporation Information
Table 49. AbbVie Description and Business Overview
Table 50. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. AbbVie Prostate Cancer Drugs Product
Table 52. AbbVie Recent Developments/Updates
Table 53. Astellas Pharma Corporation Information
Table 54. Astellas Pharma Description and Business Overview
Table 55. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Astellas Pharma Prostate Cancer Drugs Product
Table 57. Astellas Pharma Recent Developments/Updates
Table 58. Astra Zeneca Corporation Information
Table 59. Astra Zeneca Description and Business Overview
Table 60. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Astra Zeneca Prostate Cancer Drugs Product
Table 62. Astra Zeneca Recent Developments/Updates
Table 63. Johnson & Johnson Corporation Information
Table 64. Johnson & Johnson Description and Business Overview
Table 65. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Johnson & Johnson Prostate Cancer Drugs Product
Table 67. Johnson & Johnson Recent Developments/Updates
Table 68. Sanofi Corporation Information
Table 69. Sanofi Description and Business Overview
Table 70. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Sanofi Prostate Cancer Drugs Product
Table 72. Sanofi Recent Developments/Updates
Table 73. GlaxoSmithKline Corporation Information
Table 74. GlaxoSmithKline Description and Business Overview
Table 75. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. GlaxoSmithKline Prostate Cancer Drugs Product
Table 77. GlaxoSmithKline Recent Developments/Updates
Table 78. Merck Group Corporation Information
Table 79. Merck Group Description and Business Overview
Table 80. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Merck Group Prostate Cancer Drugs Product
Table 82. Merck Group Recent Developments/Updates
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Business Overview
Table 85. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Novartis Prostate Cancer Drugs Product
Table 87. Novartis Recent Developments/Updates
Table 88. Amgen Corporation Information
Table 89. Amgen Description and Business Overview
Table 90. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Amgen Prostate Cancer Drugs Product
Table 92. Amgen Recent Developments/Updates
Table 93. Bayer HealthCare Corporation Information
Table 94. Bayer HealthCare Description and Business Overview
Table 95. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Bayer HealthCare Prostate Cancer Drugs Product
Table 97. Bayer HealthCare Recent Developments/Updates
Table 98. Ferring Pharmaceutical Corporation Information
Table 99. Ferring Pharmaceutical Description and Business Overview
Table 100. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Ferring Pharmaceutical Prostate Cancer Drugs Product
Table 102. Ferring Pharmaceutical Recent Developments/Updates
Table 103. Janssen Pharmaceuticals Corporation Information
Table 104. Janssen Pharmaceuticals Description and Business Overview
Table 105. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Janssen Pharmaceuticals Prostate Cancer Drugs Product
Table 107. Janssen Pharmaceuticals Recent Developments/Updates
Table 108. Endo Pharmaceuticals Corporation Information
Table 109. Endo Pharmaceuticals Description and Business Overview
Table 110. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Endo Pharmaceuticals Prostate Cancer Drugs Product
Table 112. Endo Pharmaceuticals Recent Developments/Updates
Table 113. BMS Corporation Information
Table 114. BMS Description and Business Overview
Table 115. BMS Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. BMS Prostate Cancer Drugs Product
Table 117. BMS Recent Developments/Updates
Table 118. Takeda Pharmaceuticals Corporation Information
Table 119. Takeda Pharmaceuticals Description and Business Overview
Table 120. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Takeda Pharmaceuticals Prostate Cancer Drugs Product
Table 122. Takeda Pharmaceuticals Recent Developments/Updates
Table 123. Northwest Biotherapeutics Corporation Information
Table 124. Northwest Biotherapeutics Description and Business Overview
Table 125. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Northwest Biotherapeutics Prostate Cancer Drugs Product
Table 127. Northwest Biotherapeutics Recent Developments/Updates
Table 128. Teva Pharmaceutical Corporation Information
Table 129. Teva Pharmaceutical Description and Business Overview
Table 130. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 131. Teva Pharmaceutical Prostate Cancer Drugs Product
Table 132. Teva Pharmaceutical Recent Developments/Updates
Table 133. Boehringer Ingelheim Corporation Information
Table 134. Boehringer Ingelheim Description and Business Overview
Table 135. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 136. Boehringer Ingelheim Prostate Cancer Drugs Product
Table 137. Boehringer Ingelheim Recent Developments/Updates
Table 138. Foresee Pharmaceuticals Corporation Information
Table 139. Foresee Pharmaceuticals Description and Business Overview
Table 140. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 141. Foresee Pharmaceuticals Prostate Cancer Drugs Product
Table 142. Foresee Pharmaceuticals Recent Developments/Updates
Table 143. Tokai Pharmaceuticals Corporation Information
Table 144. Tokai Pharmaceuticals Description and Business Overview
Table 145. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 146. Tokai Pharmaceuticals Prostate Cancer Drugs Product
Table 147. Tokai Pharmaceuticals Recent Developments/Updates
Table 148. Spectrum Pharmaceuticals Corporation Information
Table 149. Spectrum Pharmaceuticals Description and Business Overview
Table 150. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 151. Spectrum Pharmaceuticals Prostate Cancer Drugs Product
Table 152. Spectrum Pharmaceuticals Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Prostate Cancer Drugs Distributors List
Table 156. Prostate Cancer Drugs Customers List
Table 157. Prostate Cancer Drugs Market Trends
Table 158. Prostate Cancer Drugs Growth Drivers
Table 159. Prostate Cancer Drugs Market Restraints
Table 160. Global Prostate Cancer Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 161. Global Prostate Cancer Drugs Sales Market Share Forecast by Type (2022-2027)
Table 162. Global Prostate Cancer Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 163. Global Prostate Cancer Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 164. Global Prostate Cancer Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 165. Global Prostate Cancer Drugs Sales Market Share Forecast by Application (2022-2027)
Table 166. Global Prostate Cancer Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 167. Global Prostate Cancer Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 168. Global Prostate Cancer Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 169. Global Prostate Cancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 170. Global Prostate Cancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 171. Global Prostate Cancer Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prostate Cancer Drugs
Figure 2. Global Prostate Cancer Drugs Market Share by Type in 2020 & 2027
Figure 3. Hormonal Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Targeted Therapy Product Picture
Figure 7. Global Prostate Cancer Drugs Market Share by Application in 2020 & 2027
Figure 8. Clinics
Figure 9. Hospitals
Figure 10. Other
Figure 11. Global Prostate Cancer Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prostate Cancer Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Prostate Cancer Drugs Sales 2016-2027 (K MT)
Figure 14. Global Prostate Cancer Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Prostate Cancer Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Prostate Cancer Drugs Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Prostate Cancer Drugs Players: Market Share by Revenue in 2020
Figure 18. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Prostate Cancer Drugs Sales Market Share by Region (2016-2021)
Figure 20. Global Prostate Cancer Drugs Sales Market Share by Region in 2020
Figure 21. Global Prostate Cancer Drugs Revenue Market Share by Region (2016-2021)
Figure 22. Global Prostate Cancer Drugs Revenue Market Share by Region in 2020
Figure 23. U.S. Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Prostate Cancer Drugs by Type (2016-2021)
Figure 48. Sales Market Share of Prostate Cancer Drugs by Application (2016-2021)
Figure 49. Sales Market Share of Prostate Cancer Drugs by Application in 2020
Figure 50. Revenue Share of Prostate Cancer Drugs by Application (2016-2021)
Figure 51. Revenue Share of Prostate Cancer Drugs by Application in 2020
Figure 52. Manufacturing Cost Structure of Prostate Cancer Drugs
Figure 53. Manufacturing Process Analysis of Prostate Cancer Drugs
Figure 54. Prostate Cancer Drugs Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs